These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17488157)

  • 1. Pathogen inactivation: the definitive safeguard for the blood supply.
    Bryant BJ; Klein HG
    Arch Pathol Lab Med; 2007 May; 131(5):719-33. PubMed ID: 17488157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogen-reduction methods: advantages and limits.
    Klein HG; Bryant BJ
    ISBT Sci Ser; 2009 Mar; 4(1):154-160. PubMed ID: 32328162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Allain JP; Bianco C; Blajchman MA; Brecher ME; Busch M; Leiby D; Lin L; Stramer S
    Transfus Med Rev; 2005 Apr; 19(2):110-26. PubMed ID: 15852240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen inactivation technology: cleansing the blood supply.
    Klein HG
    J Intern Med; 2005 Mar; 257(3):224-37. PubMed ID: 15715679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing emerging infectious threats to blood safety for the blood disorders community.
    Trimble SR; Parker CS; Grant AM; Soucie JM; Reyes N
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S468-74. PubMed ID: 20331945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy.
    Downes KA; Yomtovian R
    Clin Lab Med; 2002 Jun; 22(2):475-90. PubMed ID: 12134472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood transfusion: control of infectious risks].
    Laperche S; Lefrère JJ; Morel P; Pouchol E; Pozzetto B
    Presse Med; 2015 Feb; 44(2):189-99. PubMed ID: 25547992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of infectious pathogens in labile blood components: meeting the challenge.
    Corash L
    Transfus Clin Biol; 2001 Jun; 8(3):138-45. PubMed ID: 11499954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections.
    McCullough J
    Am J Clin Pathol; 2007 Dec; 128(6):945-55. PubMed ID: 18024320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging infectious diseases that threaten the blood supply.
    Alter HJ; Stramer SL; Dodd RY
    Semin Hematol; 2007 Jan; 44(1):32-41. PubMed ID: 17198845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmissible infections.
    Vrielink H; Reesink HW
    Curr Opin Hematol; 1998 Nov; 5(6):396-405. PubMed ID: 9814646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia therapy and blood-borne pathogen risk.
    Knight R; Stanley S; Wong M; Dolan G
    Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():3-9. PubMed ID: 16804829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions.
    JAMA; 1995 Nov; 274(17):1374-9. PubMed ID: 7563563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogen inactivation techniques.
    Pelletier JP; Transue S; Snyder EL
    Best Pract Res Clin Haematol; 2006; 19(1):205-42. PubMed ID: 16377551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates.
    Seghatchian J; Hervig T; Putter JS
    Transfus Apher Sci; 2011 Aug; 45(1):75-84. PubMed ID: 21782517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging infectious disease issues in blood safety.
    Chamberland ME; Alter HJ; Busch MP; Nemo G; Ricketts M
    Emerg Infect Dis; 2001; 7(3 Suppl):552-3. PubMed ID: 11485669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands.
    Salunkhe V; van der Meer PF; de Korte D; Seghatchian J; Gutiérrez L
    Transfus Apher Sci; 2015 Feb; 52(1):19-34. PubMed ID: 25620756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.